glp-1 receptor agonist type 1 diabetes trial liraglutide Glucagon-like peptide-1 agonists (GLP-1RAs) have become increasingly popular for the management of obesity and diabetes. You know these drugs by names like semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and (Saxenda It's important to study the
Description
Neuropsychopharmacology 35, 192216
Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study BMJ 2025

Y.HsuC.-C.et al (2024)

doi: 10.3390/life15060936

Another study reported that subjects using liraglutide, a GLP-1 RA, had attenuated responses in the cortex and insular regions of the brain when exposed to images of food in the fasting state compared to the control group [6]

doi: 10.1016/S0140-6736(21)02188-7 [DOI] [PubMed] [Google Scholar] 263